NCM USA BRONX LLC FDA Approval ANDA 204513

ANDA 204513

NCM USA BRONX LLC

FDA Drug Application

Application #204513

Application Sponsors

ANDA 204513NCM USA BRONX LLC

Marketing Status

Prescription001

Application Products

001INJECTABLE;INTRAVENOUS10-200mCi/ML0SODIUM FLUORIDE F-18SODIUM FLUORIDE F-18

FDA Submissions

UNKNOWN; ORIG1AP2014-11-28

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAP

CDER Filings

NCM USA BRONX LLC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 204513
            [companyName] => NCM USA BRONX LLC
            [docInserts] => ["",""]
            [products] => [{"drugName":"SODIUM FLUORIDE F-18","activeIngredients":"SODIUM FLUORIDE F-18","strength":"10-200mCi\/ML","dosageForm":"INJECTABLE;INTRAVENOUS","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"11\/28\/2014","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2014-11-28
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.